XML 67 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Financial Instruments and Fair Value Measurements (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 28, 2025
Mar. 29, 2024
Dec. 27, 2024
Mar. 13, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Derivative, Notional Amount       $ 860.0
Derivative, Interest Rate Cap, Premium       $ 20.0
Derivative, Cap Interest Rate       3.84%
Equity Securities, FV-NI, Unrealized Gain (Loss) $ (6.2) $ 7.0    
Other Assets, Fair Value Disclosure 5.8   $ 12.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 2.7   5.3  
Assets, Fair Value Disclosure 33.7   42.7  
Interest Rate Cap        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Unrealized Gain (Loss) on Derivatives 2.6 2.1    
Embedded Derivative Financial Instruments        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Unrealized Gain (Loss) on Derivatives 5.9      
Recurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Derivative Liability 0.0   0.0  
Investments, Fair Value Disclosure 25.2   25.4  
Deferred Compensation Liability, Fair Value 19.5   22.5  
Contingent consideration and acquired contingent liabilities 17.4   17.5  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 36.9   40.0  
Level 3 | Other current and non-current assets        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Cash surrender value of life insurance 44.1   43.7  
Level 3 | Recurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Investments, Fair Value Disclosure 0.0   0.0  
Other Assets, Fair Value Disclosure 0.0   0.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 0.0   0.0  
Assets, Fair Value Disclosure 0.0   0.0  
Deferred Compensation Liability, Fair Value 0.0   0.0  
Contingent consideration and acquired contingent liabilities 17.4   17.5  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 17.4   17.5  
Level 3 | Recurring | Contingent Liabilities        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Fair value adjustment (0.1) $ 1.4    
Level 2 | Recurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Investments, Fair Value Disclosure 8.4   8.0  
Other Assets, Fair Value Disclosure 0.0   0.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 2.7   5.3  
Assets, Fair Value Disclosure 11.1   13.3  
Deferred Compensation Liability, Fair Value 19.5   22.5  
Contingent consideration and acquired contingent liabilities 0.0   0.0  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 19.5   22.5  
Level 1 | Recurring        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Investments, Fair Value Disclosure 16.8   17.4  
Other Assets, Fair Value Disclosure 5.8   12.0  
Cash Flow Hedge Derivative Instrument Assets at Fair Value 0.0   0.0  
Assets, Fair Value Disclosure 22.6   29.4  
Deferred Compensation Liability, Fair Value 0.0   0.0  
Contingent consideration and acquired contingent liabilities 0.0   0.0  
Financial and Nonfinancial Liabilities, Fair Value Disclosure 0.0   0.0  
Indemnification Agreement | Level 1        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis        
Restricted Cash and Cash Equivalents $ 63.5   $ 63.1